ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,772, issued on Oct. 14, was assigned to Molecular Partners AG (Schlieren, Switzerland).
"Designed ankyrin repeat domain with improved stability" was invented by Johannes Schilling (Schlieren, Switzerland) and Marcel Walser (Schlieren, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to designed ankyrin repeat domains with binding specificity for serum albumin and, in particular, to such designed ankyrin repeat domains with improved stability. The disclosure further relates to recombinant binding proteins comprising such designed ankyrin repeat domain(s), nucleic acids encoding such designed ankyrin repeat dom...